Chemical Research in Chinese Universities ›› 2014, Vol. 30 ›› Issue (2): 297-305.doi: 10.1007/s40242-014-3395-5

• Articles • Previous Articles     Next Articles

Pharmacophore and Docking-based 3D-QSAR Studies on HIV-1 Integrase Inhibitors

ZHANG Xiaoyi1, DENG Dongjie1, TAN Jianjun1, HE Yu2, LI Chunhua1, WANG Cunxin1   

  1. 1. College of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, P. R. China;
    2. College of Materials Science and Engineering, Beijing University of Technology, Beijing 100124, P. R. China
  • Received:2013-09-17 Revised:2013-12-02 Online:2014-04-01 Published:2014-01-23
  • Contact: LI Chunhua, WANG Cunxin E-mail:cxwang@bjut.edu.cn;chunhuali@bjut.edu.cn
  • Supported by:

    Supported by the National Natural Science Foundation of China(Nos.31100523, 31171267, 21173014) and the Beijing Outstanding Personnel Training Foundation, China(No.2012D005015000006).

Abstract:

Integrase(IN) plays an essential role in the process of HIV-1 replication. IN inhibitors of diketo acid derivatives(DKAs) were analysed by the Comparative Molecular Field Analysis(CoMFA) and Comparative Molecular Similarity Induces Analysis(CoMSIA) methods. A set of 42 compounds were randomly selected as the training set(35) and test set(7). Firstly, a good pharmacophore(goodness of hit=0.787) was obtained and used to align ligands. Then, predictive models were constructed with the CoMFA and CoMSIA methods based on the pharmacophore alignment. As a result, the CoMSIA method yielded the best model with an r2 of 0.955 and a q2 of 0.665, which can predict the activities of the tested DKAs very well(r2=0.559). Finally, DKAs were docked into IN, and the predicit modes were superimposed on the contour maps obtained from the best CoMSIA model. The superimposed maps gave a visualized and meaningful insight into the inhibitory behaviors, providing significantly useful information for the rational drug design of anti-IN agents.

Key words: HIV-1 integrase, Diketo acid, Quantitative structure-activity relationship, Pharmacophore, Molecular docking